Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Repligen Corporation

Market Cap 744.69Cr 649.3Cr 601.36Cr 562.94Cr 1.06TCr 70TCr 1.06TCr 7.13TCr 2.76TCr 35TCr 2.8TCr 2.74TCr 1,20100Cr P/E 2026 *
121x
P/E 2027 * 73.5x
Enterprise Value 719.25Cr 627.12Cr 580.81Cr 543.71Cr 1.02TCr 68TCr 1.03TCr 6.89TCr 2.67TCr 33TCr 2.7TCr 2.64TCr 1,16000Cr EV / Sales 2026 *
8.74x
EV / Sales 2027 * 7.42x
Free-Float
94.26%
Yield 2026 *
-
Yield 2027 * -
1 day-1.15%
1 week-0.98%
Current month+6.51%
1 month+26.70%
3 months+12.27%
6 months-16.29%
Current year-19.43%
1 week 127.48
Extreme 127.48
136.54
1 month 103.63
Extreme 103.63
136.54
Current year 100.99
Extreme 100.99
175.77
1 year 100.99
Extreme 100.99
175.77
3 years 100.99
Extreme 100.99
211.13
5 years 100.99
Extreme 100.99
327.32
10 years 21.45
Extreme 21.45
327.32
Manager TitleAgeSince
Chief Executive Officer 56 01/09/2024
Director of Finance/CFO 52 25/09/2023
Chief Tech/Sci/R&D Officer - 01/08/2025
Director TitleAgeSince
Chairman 74 14/12/2011
Director/Board Member 60 12/06/2014
Director/Board Member 67 01/10/2015
Date Insider Type Main position Quantity % Market Cap.
14/05Free

Director

3,234 0.0057%
14/05Free

Director

3,234 0.0057%
14/05Free

Director

3,234 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.15%-0.98%+12.32%-16.16% 744.69Cr
-0.10%-1.38%-33.23%-16.75% 15TCr
+1.54%-1.23%-7.45%-11.00% 10TCr
-4.45%+6.22%+58.91%+55.60% 5.93TCr
-1.90%-3.43%-8.40%+48.53% 5.29TCr
+1.67%-2.29%-14.60%-44.33% 3.97TCr
-1.32%-3.20% - - 3.04TCr
+1.74%-3.69%-10.54%-44.30% 2.8TCr
-1.25%-0.72%+50.47%-9.42% 2.32TCr
-1.53%-1.74%-15.43%-3.81% 2.07TCr
Average -0.42%-0.55%+3.56%-4.63% 5.17TCr
Weighted average by Cap. -0.30%-0.21%-5.67%-2.58%

Financials

2026 *2027 *
Net sales 82Cr 72Cr 66Cr 62Cr 116.68Cr 7.77TCr 117.39Cr 788.44Cr 305.57Cr 3.82TCr 308.94Cr 302.32Cr 13TCr 95Cr 82Cr 76Cr 71Cr 133.99Cr 8.92TCr 134.8Cr 905.36Cr 350.88Cr 4.39TCr 354.76Cr 347.15Cr 15TCr
Net income 6.11Cr 5.33Cr 4.93Cr 4.62Cr 8.66Cr 576.44Cr 8.71Cr 59Cr 23Cr 283.73Cr 23Cr 22Cr 985.2Cr 10Cr 8.82Cr 8.17Cr 7.65Cr 14Cr 954.66Cr 14Cr 97Cr 38Cr 469.9Cr 38Cr 37Cr 1.63TCr
Net Debt -25Cr -22Cr -21Cr -19Cr -36Cr -2.4TCr -36Cr -243.74Cr -94Cr -1.18TCr -96Cr -93Cr -4.1TCr -43Cr -38Cr -35Cr -33Cr -61Cr -4.08TCr -62Cr -413.72Cr -160.34Cr -2.01TCr -162.11Cr -158.63Cr -6.96TCr
Logo Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.
Employees
2,000
Date Price Change Volume
18/26/18 132.02 $ -1.15% 12,36,920
17/26/17 133.55 $ +1.41% 13,52,544
16/26/16 131.69 $ +0.63% 6,12,354
15/26/15 130.87 $ +0.21% 6,33,247
12/26/12 130.59 $ -2.06% 13,38,022
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
132.02USD
Average target price
176.11USD
Spread / Average Target
+33.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RGEN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!